deprivation or profound low glucose concentration in the brain, which manifest as confusion, sensation of warmth, blurred speech, fatigue, cognitive failure, seizures, coma, and death if unattended. 3, 4 During the early stage of neuroglycopenia, cortical dysfunction might only be recognized through a systematic cognitive testing. 5, 7 Cerebral cortical dysfunction has been recorded when BG concentration is 36 mg/dL (2 mmol/L) or less in humans and rats. 1, 2 At that low glucose level, brain glucose concentration was reported to be close to zero. 1, 2 Measurement of glucose concentration in cerebrospinal fluid (CSF) might aid to investigate glucose concentration in the brain. 8, 9 Low glucose concentration in CSF is termed hypoglycorrhachia and is most commonly associated with infection (mainly bacterial meningitis) but other causes such as stroke, malignancy, neurosarcoidosis, and severe hypoglycemia are associated with low CSF glucose concentrations. 10, 11 The effects of hypoglycemia on brain function through electroencephalography (EEG) have been studied in patients with and without insulin dependent diabetes. 2, 12, 13 Through the collection of serial blood samples, it was determined that blood glucose concentration above 54 mg/dL (3 mmol/L) did not cause alterations in EEG activity. 2 Cortical neuronal dysfunction was shown as an abrupt decrease in alpha activity with a concomitant increase in theta activity at a median blood glucose concentration of 36 mg/dL (2 mmol/L). 2 Further, changes in EEG activity appear and disappear within a narrow range of blood glucose concentrations. 2 However, there is variability among individuals manifesting neurologic dysfunction and EEG alterations associated with hypoglycemia. 14 In addition to hypoglycemia, alterations in glucose transport, metabolism, and storage of glycogen can cause or contribute to low glucose concentrations in the brain. 9, 15 Hypoglycemia has been reported in horses and defined as a BG concentration below 75 mg/dL (< 4.2 mmol/L). 16, 17 Although seizures associated with hypoglycemia have been sporadically reported in veterinary medicine, comprehensive clinical descriptions of the effects of hypoglycemia on neurologic findings, documentation of hypoglycorrhachia and presumed neuroglycopenia and its associated electroencephalographic findings have not been reported in horses. [18] [19] [20] [21] Further, there are no studies correlating low glucose concentrations in blood and CSF in equine medicine. 22, 23 Therefore, the objective of the study was to report neurological signs in horses with severe hypoglycemia. Furthermore, glucose concentration in CSF and EEG findings were reported when available. Our testing hypothesis was that hypoglycorrhachia and presumed neuroglycopenia manifested as severe neurologic dysfunction occur in horses with severe hypoglycemia. Ranch, CA) with integrated video was used to obtain all standard EEG, EOG, and ECG recordings. Electrode nomenclature and placement was based from a modified human 10-20 system and described in horses previously. 24, 25 Needle electrodes were placed subcutaneously in the scalp of horses for the recording of the EEG as described elsewhere. 25 In brief, subcutaneous needle electrodes were placed in the prefrontal (2 electrodes), frontal (3), central (3), parietal (3) and occipital (2) regions. Additional electrodes included 1 that served as a ground (between the 2 prefrontal electrodes, 1 in the intercanthus region and 1 at the base of each ear to evaluate for ear movement artifacts on the EEG. Concurrently, an electrooculogram (2 subcutaneous electrodes per eye, 1 each in the upper and lower eyelids), electromyogram (2 subcutaneous electrodes located in the splenius muscle), and electrocardiogram (1 subcutaneous electrode in the region of the left heart base and 1 at the left heart apex) were also performed. A bipolar montage (rostral to caudal and transverse) was used with sensitivities set for recording as described. 24, 25 Thirty to forty minutes of EEG recordings were obtained. The data obtained was thoroughly examined from EEG tracings and simultaneous video of the horse under study. The EEG study was approved by an animal care and use protocol from our institution and clients consented to perform an EEG. 
| MATERIALS AND METHODS

| Animals
| Statistical Analysis
| Glucose Concentration
For this section, glucose concentration will be reported as mg/dL. One foal less than a month of age had a BG concentration of [Correction added after first online publication 31 August 2018: in Table 1 formatting has been updated.]
72 mg/dL; and 3 foals had 0, 6, and 25 mg/dL each. Four older horses up to a year of age had mild hypoglycemia (51, 56, 69 , and 70 mg/dL). Table 1 
| Outcome
The overall hospital mortality rate for these 90 horses was 48%
(euthanasia = 28/90, died = 15/90 horses) ( Table 2) . Mortality appeared to be higher in foals less than a one month of age (N = 20/39, 51.3%) than older foals and adults. By group, the case fatality rate was 51, 50, 0, and 49% for the neonatal, non-neonatal foals, ≤ 1 year, and adult horses, respectively ( Table 2 ). The overall fatality rate was 34 and 58% for horses with mild and severe hypoglycemia, respectively (Table 2) . However, a significant association between BG concentration and outcome was not identified. Macroscopic postmortem evaluation of the brain was available for 10 horses and did not reveal alterations. Histological evaluation of the brain was not available.
| DISCUSSION
This study reports horses with presumed neuroglycopenia based on the presence of neurological signs such as altered state of consciousness, seizures, disorientation, and intermittent blindness and deafness; along with hypoglycemia which in 57% of horses was profound. Furthermore, CSF glucose concentration was severely low and likely reflecting glucose concentration in the brain as reported in human medicine. 9 Paroxysmal activity in support of seizures in the parietal and occipital cortical region was seen in all horses on which an EEG was performed. Therefore, this study also highlights the importance of performing an EEG examination for the investigation of paroxysmal activity in support of seizures even in the absence of clinical manifestations.
Disorders causing hypoglycemia include those resulting in increased glucose utilization and/or decreased glucose production, altered metabolism, transport and storage. 17 Examples of conditions resulting in hypoglycemia in horses include sepsis, endotoxemia, liver failure, illnesses impairing neonatal foals from nursing, and glycogenosis such as glycogen branching enzyme deficiency in neonatal Quarter
Horses. 16, 17, [27] [28] [29] Starvation and severe malnutrition are less common causes of hypoglycemia. Delayed serum or plasma separation from blood cells and hyperlipemia can result in falsely low BG concentration. Although hypoglycemia has been reported in equids of various ages; neurological signs have been scarcely described. 16, 17 Neurogenic signs such as those described in humans with mild hypoglycemia were rarely documented here. 
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Recurrent hypoglycemic episodes can lead to blunting of mild Figure 2A . Baseline EEG recording while the mare was on IV dextrose administration. Heart rate = 30 bpm. Blood glucose concentration at the time of this recording was 83 mg/dL. Figure 2B . Electroencephalogram showing slowing of waves throughout this epoch of 10 seconds. This recording was made within 1 minute of discontinuing IV dextrose administration. Note sharp wave (arrow), spike and wave (oval) on occipital cortical region (O1-O2 channel) following cessation of IV dextrose drip. Heart rate = 36 bpm. Figure 2C . Electroencephalogram showing multiple spikes and waves (throughout O1-O2) and sharp waves (*) noted on occipital and parietal region. No IV dextrose administered during this 10 second epoch. Frontal polar channel is picking up eye movement artifacts: eye movement (EM) and blink (B). Heart rate = 36 bpm. Figure 2D . Note increased paroxysmal discharges in occipital and parietal regions. No IV dextrose administration during this recording. Heart rate = 42 bpm. Blood glucose concentration at the time of this recording was 44 mg/dL. Figure 2E . Electroencephalogram showing paroxysmal activity mixed with movement artifact as the filly is having a clinical seizure manifested as facial twitching and eye rolling. Blood glucose during this recording was 23 mg/dL. Heart rate = 36 bpm. Figure 2F . Electroencephalogram during seizures. Note spread of paroxysmal activity, movement, and loss of electrodes. Note irregular ECG activity. After this recording, IV dextrose administration was resumed and EEG activity returned to normal symptoms in people resulting in hypoglycemia unawareness and risk of progressing to neuroglycopenic symptoms. 14, 34 In veterinary medicine, mild hypoglycemic clinical manifestations might be more difficult to recognize and therefore missed. Furthermore, other disease processes can result in similar non-specific clinical signs.
Hypoglycemia is a leading cause of neurological signs and sequelae in infants with severe metabolic or infectious diseases. 35 Cortical white matter hemorrhage, basal nuclei and thalamic injury, and infarction in areas of the middle cerebral artery resulting in neurologic symptoms and later neurodevelopmental impairment have been documented in up to 94% of newborn infants with hypoglycemia. 36, 37 This injury has been dependent on duration and severity of hypoglycemia. 36 Reference ranges for blood glucose concentration in neonatal foals have been reportedly higher than older foals and adult horses. 17, 38 The reference range of blood glucose concentration for neonatal foals at our institution is reported to be from 118 to 207 mg/dL (6.6 to 11.5 mmol/L). Glucose concentration in CSF can be similar or slightly lower to that of BG in healthy adult horses; but it could range from 40 to 70 mg/dL (2.2 to 3.9 mmol/L). 16 Hypoglycemia has been reported to occur in 29% of critically ill neonatal foals. 16 This is because neonatal foals are born with very low fat and glycogen stores, therefore any illness that interferes with getting adequate nutrition can result in hypoglycemia. 40 Hypoglycemia in neonatal foals was associated with nonsurvival to hospital discharge. 16 Furthermore, extreme hypoglycemia defined as blood glucose below 50 mg/dL (< 2.8 mmol/L) was associated with sepsis, a positive blood culture and nonsurvival compared to animals with higher blood glucose concentrations. 17 In the current study, the majority of neonatal foals were diagnosed with sepsis (N = 25/35), of which 17 had severe hypoglycemia. Thirteen (57%) of 23 foals with severe hypoglycemia died or were euthanized. Similar to other reports, foals from our study with severe liver disease such as those with Tizzer's developed severe hypoglycemia. 33, 41 Hypoglycemia is less common in adult horses compared to neonatal foals and has been associated with liver failure, abdominal disease, critical illness, and neoplasia (hepatic and renal). 17, 18, 42 In our study, the most common causes associated with hypoglycemia in adult horses included liver and gastrointestinal disease (33% each), followed by hypertriglyceridemia (18%). Hypoglycemia is the most common adverse effect of insulin treatment in humans with type 1 diabetes and insulin-dependent type 2 diabetes. 43, 44 Hypoglycemia and seizures as the result of insulin therapy were also observed in our study (N = 4/8) and corrected with IV dextrose administration and adjustment of insulin therapy. Renal adenocarcinoma, renal anaplastic carcinoma, papillary renal adenoma, hepatocellular carcinoma, cholangiocarcinoma, peritoneal mesothelioma, and gastrointestinal stromal tumor have been associated with hypoglycemia and presumed to be associated with the release of insulin growth-like factor. 17, 18, 42, [45] [46] [47] [48] [49] In these horses, BG concentration was usually low ranging from 13 to 65 mg/dL (0.7 to 3.6 mmol/L). Descriptions of altered mentation and seizures were not always reported. 18 In our horses, intermittent to persistent hypoglycemia ranging from 13 to 56 mg/dL (0.7 to 3.1 mmol/L) was observed. All of these horses had neurologic abnormalities (obtundation N = 6/7, seizures N = 4/7). Possible causes for hypoglycemia in these horses could have included intermittent or persistent secretion of insulin growth-like factor by non-islet cell tumors (non-islet cell tumor-induced hypoglycemia [NICTH] ) and paraneoplastic hypoglycemia as described in humans. [50] [51] [52] [53] Concentrations of insulin-growth factors I and II for the documentation of NICTH was not performed in these horses. 53 Electroencephalography reflects the metabolic state of the brain. 3 Hypoglycemic episodes have been associated with EEG changes that could serve as predictors of severe hypoglycemia in humans. 54, 55 The earliest abnormalities reported in mice included an increase in the power of the delta and theta band relative to the power in the alpha band. 3 Reported EEG alterations include a decrease in alpha frequencies and an increase in delta frequencies following with gradual aggravation in EEG alterations as hypoglycemia progresses. 55 Alpha/theta ratio is a sensitive parameter for detecting changes in EEG during hypoglycemia. 55 Paroxysmal discharges supportive of epileptic activity consist of sharp waves (70-200 milliseconds) and spikes (< 70 ms) and waves. 56 These discharges were observed in some horses despite the lack of obvious clinical manifestations of seizures supporting subclinical paroxysmal (epileptic) activity. However, altered behavior and mentation could be manifestations of paroxysmal activity. As an example, one mare on which an IV dextrose infusion was discontinued, paroxysmal activity was observed prior to any clinical manifestations of seizures (Figure 2 ). Continuous EEG recording in this mare showed an increase in paroxysmal activity that became generalized. Concurrently, the mare developed clinical manifestations of seizure activity which subsided when IV dextrose infusion was resumed.
In humans, a topographic maximum of slow frequencies is found in the frontal cortex at glucose levels of 50 to 60 mg/dL. there is a shift toward the posterior parts of the brain, and overall changes in the EEG are more pronounced in the parietal-occipital and temporal regions at blood glucose levels of 36 mg/dL (2 mmol/L).
2,55
Generalized slowing is followed by spikes as the severity of hypoglycemia worsens. 3 Alterations of the EEG during hypoglycemia might not be identical in all patients but tend to be reproducible in each patient. 57 Similarly, EEG alterations in this study included slow fre- 
